CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1121 - 1130 of 1145
Study Number Lead Group Study Title CIRB Study Status
URCC-22053 NCORP-University of Rochester Cancer Center High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients Cancer Prevention and Control CIRB Available to Open
URCC-22063 NCORP-University of Rochester Cancer Center LOTUS-CC: Longitudinal Observational Trial to Uncover Subtypes of Cancer Cachexia Cancer Prevention and Control CIRB Available to Open
URCC-23086CD NCORP-University of Rochester Cancer Center Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice Cancer Prevention and Control CIRB Available to Open
UWI20-00-01 CP-CTNet_CLO-University of Wisconsin A Phase II Trial of the Immunogenicity of a DNA Plasmid Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes from Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Participants with Early Stage Triple Negative Breast Cancer Cancer Prevention and Control CIRB Available to Open
UWI20-04-01 CP-CTNet_CLO-University of Wisconsin A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, a Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer Cancer Prevention and Control CIRB Available to Open
UWI2014-03-01 CP-CTNet_CLO-University of Wisconsin A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine (WOKVAC) Encoding Epitopes Derived from Three Breast Cancer Antigens (IGFBP-2, HER2, AND IGF-1R) in Patients with Breast Cancer Cancer Prevention and Control CIRB Available to Open
UWI2015-05-01 CP-CTNet_CLO-University of Wisconsin Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CP-CTNet_CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Completed
UWI2016-08-01 CP-CTNet_CLO-University of Wisconsin Pilot Study of Daily Exemestane in Women with Complex Atypical Hyperplasia of the Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer Cancer Prevention and Control CIRB Available to Open
UWI21-06-01 CP-CTNet_CLO-University of Wisconsin Pilot study of GCC agonists to identify a cyclic-GMP signal in duodenal tissue of volunteers Cancer Prevention and Control CIRB Available to Open
Displaying 1121 - 1130 of 1145